Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benza

Showing results (141-150 of 361) with videos related to

Pageof 37
Sort By:
Alcoholism, Clinical and Experimental Research|May 15, 1998
Alcohol-induced upregulation of plasminogen activators and fibrinolytic activity in cultured human endothelial cellsM L Aikens, H E Grenett, R L Benza, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 15, 2014
Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distanceHarrison W Farber, Dave P Miller, Michael D McGoon, et al.
Chest|June 25, 2023
Do Patients With Low-Risk Pulmonary Arterial Hypertension Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION TrialCharles Fauvel, Yongqi Liu, Priscilla Correa-Jaque, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 13, 2001
Cardiomyopathy in a carrier of Duchenne's muscular dystrophyJ E Davies, T S Winokur, M F Aaron, et al.
Proceedings of the American Thoracic Society|July 16, 2008
Surrogate and combined end points in pulmonary arterial hypertensionCorey E Ventetuolo, Raymond L Benza, Andrew J Peacock, et al.
Chest|August 3, 2013
Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL Registry analysisAdaani E Frost, David B Badesch, Dave P Miller, et al.
Advanced Healthcare Materials|July 31, 2025
Toward Noninvasively Imaging pH at the Surface of Implanted Orthopedic Devices in Live Rabbits Using X-ray Excited Luminescence Chemical ImagingUnaiza Uzair, Fenglin Wang, Donald Benza, et al.
The Annals of Thoracic Surgery|September 4, 1999
Infection during circulatory support with ventricular assist devicesW L Holman, J L Skinner, K B Waites, et al.
Marine Drugs|April 25, 2025
Polyunsaturated Fatty Acids Improved Long Term Prognosis by Reducing Oxidative Stress, Inflammation, and Endothelial Dysfunction in Acute Coronary SyndromesAlexandru Covaciu, Theodora Benedek, Elena Bobescu, et al.
Respiratory Medicine|November 27, 2016
Rationale and study design of RESPITE: An open-label, phase 3b study of riociguat in patients with pulmonary arterial hypertension who demonstrate an insufficient response to treatment with phosphodiesterase-5 inhibitorsMarius M Hoeper, James R Klinger, Raymond L Benza, et al.
Pageof 37

Showing results (141-150 of 361) with videos related to

Sort By:
Pageof 37
Alcoholism, Clinical and Experimental Research|May 15, 1998
Alcohol-induced upregulation of plasminogen activators and fibrinolytic activity in cultured human endothelial cellsM L Aikens, H E Grenett, R L Benza, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 15, 2014
Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distanceHarrison W Farber, Dave P Miller, Michael D McGoon, et al.
Chest|June 25, 2023
Do Patients With Low-Risk Pulmonary Arterial Hypertension Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION TrialCharles Fauvel, Yongqi Liu, Priscilla Correa-Jaque, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 13, 2001
Cardiomyopathy in a carrier of Duchenne's muscular dystrophyJ E Davies, T S Winokur, M F Aaron, et al.
Proceedings of the American Thoracic Society|July 16, 2008
Surrogate and combined end points in pulmonary arterial hypertensionCorey E Ventetuolo, Raymond L Benza, Andrew J Peacock, et al.
Chest|August 3, 2013
Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL Registry analysisAdaani E Frost, David B Badesch, Dave P Miller, et al.
Advanced Healthcare Materials|July 31, 2025
Toward Noninvasively Imaging pH at the Surface of Implanted Orthopedic Devices in Live Rabbits Using X-ray Excited Luminescence Chemical ImagingUnaiza Uzair, Fenglin Wang, Donald Benza, et al.
The Annals of Thoracic Surgery|September 4, 1999
Infection during circulatory support with ventricular assist devicesW L Holman, J L Skinner, K B Waites, et al.
Marine Drugs|April 25, 2025
Polyunsaturated Fatty Acids Improved Long Term Prognosis by Reducing Oxidative Stress, Inflammation, and Endothelial Dysfunction in Acute Coronary SyndromesAlexandru Covaciu, Theodora Benedek, Elena Bobescu, et al.
Respiratory Medicine|November 27, 2016
Rationale and study design of RESPITE: An open-label, phase 3b study of riociguat in patients with pulmonary arterial hypertension who demonstrate an insufficient response to treatment with phosphodiesterase-5 inhibitorsMarius M Hoeper, James R Klinger, Raymond L Benza, et al.
Pageof 37